Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prima BioMed Ltd (NASDAQ:PBMD)

1.49
Delayed Data
As of Sep 01
 +0.292 / +24.37%
Today’s Change
0.42
Today|||52-Week Range
6.48
+122.35%
Year-to-Date
No recent news for Prima BioMed Ltd.

Today’s Trading

Previous close1.20
Today’s open1.19
Day’s range1.16 - 1.60
Volume5,068,622
Average volume (3 months)2,131,118
Market cap$54.9M
Dividend yield--
Data as of 3:59pm ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)+23.24%
Earnings growth (this year)+34.41%
Earnings growth (next 5 years)+0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.17

Competitors

 Today’s
change
Today’s
% change
BCLIBrainstorm Cell Ther...0.000.00%
--Protea Biosciences G...0.000.00%
IMUCImmunoCellular Thera...+0.00+0.07%
HTGMHTG Molecular Diagno...+0.27+4.94%
Data as of 4:01pm ET, 09/01/2015

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$13.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Marc Voigt
Chief Technology Officer
Sharron E. Gargosky
Corporate headquarters
Sydney, New South Wales (nsw)

Forecasts

Partner Offers